Skip to content

Clinical trials

Pre-Eclampsia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pre-Eclampsia Country / region: China Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20163
20173
20181
20194
20202
20214
20224
20234
20245
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status14
Completed13
Recruiting4
Not yet recruiting2
Active, not recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
General Hospital of Ningxia Medical University4
FANG HE3
Chinese University of Hong Kong2
Chiu Yee Liona Poon2
Dunjin Chen2
Peking University Third Hospital2
The Third Affiliated Hospital of Guangzhou Medical University2
Xiamen Amoytop Biotech Co., Ltd.2
Fang Wang1
First Affiliated Hospital of Harbin Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pre-Eclampsia36
Hypertension3
Premature Birth3
Eclampsia2
Hypertension, Pregnancy-Induced2
Abortion, Habitual1
Fetal Growth Retardation1
Maternal Death1
Obesity1
Posterior Leukoencephalopathy Syndrome1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.